| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |